KRAS and colorectal carcinoma: Consistent with the colorectal cell lines (Figure 4A), MYC, SUZ12, and KRAS were all upregulated in the primary tumors compared with those in normal tissues, indicating the intrinsic oncogenes of these biotargets in CRC.